May 2021 Journal Club @ Retina Specialists
Retina Specialists hosts a Journal Club for ophthalmic professionals in the Auckland region every six weeks. We will discuss the latest developments in retinal research and their application to clinical practice.
Topics for Journal Club in May 2021, and papers to be discussed:
Dr Leo Sheck - Optimal Management of Polypoidal Choroidal Vasculopathy
Non ICGA treatment criteria for Suboptimal Anti VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2. Ophthalmology Retina (2021) doi:10.1016/j.oret.2021.04.002.
Koh, A. et al. EVEREST STUDY: Efficacy and Safety of Verteporfin Photodynamic Therapy in Combination with Ranibizumab or Alone Versus Ranibizumab Monotherapy in Patients with Symptomatic Macular Polypoidal Choroidal Vasculopathy. Retina 32, 1453–1464 (2012).
Koh, A. et al. Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial. JAMA Ophthalmol 135, 1206 (2017).
Lim, T. H. et al. Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial. JAMA Ophthalmol 138, 935 (2020).
Lee, W. K. et al. Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial. JAMA Ophthalmol 136, 786 (2018).
Wong, T. Y. et al. Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study. American Journal of Ophthalmology 204, 80–89 (2019).
Dr Rachel Barnes - Emergent Treatment for Geographic Atrophy
Jaffe, G. J. et al. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration. Ophthalmology 128, 576–586 (2021).
Registration has now closed for this Journal Club, but please keep an eye on the News page for the next meeting